Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coronary Artery Disease
|
1022 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.030 | 1.000 | 3 | 2010 | 2014 | |||||
Asthma
|
714 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||
Neoplasm Metastasis
|
327 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.020 | 1.000 | 2 | 2005 | 2007 | |||||
Allergic asthma
|
55 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Angle Closure Glaucoma
|
56 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Behcet Syndrome
|
202 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Breast Carcinoma
|
2145 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Carcinoma of lung
|
995 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1 | 2005 | 2005 | ||||||
Chronic Kidney Diseases
|
155 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Colorectal Carcinoma
|
1186 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1 | 2012 | 2012 | ||||||
Endometriosis
|
207 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Gallbladder Carcinoma
|
65 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1 | 2014 | 2014 | ||||||
Hay fever
|
20 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
IgE-mediated allergic asthma
|
46 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Malignant neoplasm of breast
|
2154 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Malignant neoplasm of gallbladder
|
65 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1 | 2014 | 2014 | ||||||
Malignant neoplasm of lung
|
1000 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1 | 2005 | 2005 | ||||||
Malignant Neoplasms
|
1441 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1 | 2018 | 2018 | ||||||
melanoma
|
352 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Non-Small Cell Lung Carcinoma
|
601 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Primary angle-closure glaucoma
|
55 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Primary malignant neoplasm
|
1374 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1 | 2018 | 2018 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1 | 2005 | 2005 | ||||||
Squamous cell carcinoma
|
197 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.649 | 0.520 | 20 | 46014472 | missense variant | G/A;C | snv | 0.16 | 0.010 | 1 | 2014 | 2014 |